DNA2 and cancer: These results have significant impact on our goal of using inhibition of DNA2 to increase the therapeutic index for treating Fanconi anemia patients with various cancers by protecting normal, non-cancerous cells from chemotherapeutics that stall replication forks and by limiting inflammation.